gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Hemorrhage in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Clarisse, J; Dewailly, D; Fossati, P; Hamon-Kérautret, M; Leclerc, X; Pruvo, JP | 1 |
Alanen, A; Dean, PB; Kormano, M; Määttänen, H; Niemi, P; Paajanen, H | 1 |
2 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Hemorrhage
Article | Year |
---|---|
Pituitary microadenomas: experience with Gd-DOTA-enhanced MR imaging at 0.5 Telsa.
Topics: Adenoma; Adolescent; Adrenocorticotropic Hormone; Adult; Contrast Media; Female; Gadolinium; Hemorrhage; Heterocyclic Compounds; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Pituitary Neoplasms; Prolactin; Prolactinoma; Prospective Studies; Sella Turcica | 1994 |
MR imaging of experimental intramuscular hemorrhage at 0.02 T. Contrast enhancement with Gd-DOTA.
Topics: Animals; Hemorrhage; Heterocyclic Compounds; Magnetic Resonance Imaging; Muscular Diseases; Organometallic Compounds; Rabbits; Radiographic Image Enhancement | 1990 |